Takaki Yoshikawa Selected Research

Stomach Neoplasms (Stomach Cancer)

11/2022	Usefulness of an S-1 dosage formula: an exploratory analysis of randomized clinical trial (JCOG1001).
10/2022	Feasibility and Safety of Oral Nutritional Supplementation with High-Density Liquid Diet After Total Gastrectomy for Gastric Cancer.
6/2022	Long-term postoperative pneumonia in elderly patients with early gastric cancer.
5/2022	Effects of perioperative eicosapentaenoic acid-enriched oral nutritional supplement on the long-term oncological outcomes after total gastrectomy for gastric cancer.
3/2022	Negative impact of intraoperative blood loss on long-term outcome after curative gastrectomy for advanced gastric cancer: exploratory analysis of the JCOG1001 phase III trial.
2/2022	Pathological complete response at the para-aortic nodes as a possible surrogate endpoint in gastric cancer surgery with para-aortic node dissection after neoadjuvant chemotherapy.
1/2022	Association of renal function with the safety and efficacy of cisplatin plus S-1 therapy and docetaxel plus cisplatin plus S-1 therapy in patients with advanced gastric cancer: an exploratory analysis of JCOG1013.
1/2022	Machine-learning model derived gene signature predictive of paclitaxel survival benefit in gastric cancer: results from the randomised phase III SAMIT trial.
1/2022	Suprapancreatic nodal dissection should not be uniformly selected in additional gastrectomy for the patients who diagnosed as pT1b gastric cancer by endoscopic resection.
1/2022	A multicenter, open-label, single-arm phase I trial of neoadjuvant nivolumab monotherapy for resectable gastric cancer.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Takaki Yoshikawa Research Topics

Disease

214	Stomach Neoplasms (Stomach Cancer) 11/2022 - 01/2002
108	Neoplasms (Cancer) 06/2022 - 01/2002
46	Neoplasm Metastasis (Metastasis) 05/2022 - 01/2002
18	Body Weight (Weight, Body) 10/2022 - 11/2003
17	Adenocarcinoma 01/2022 - 03/2006
17	Lymphatic Metastasis 01/2021 - 07/2002
12	Pancreatic Neoplasms (Pancreatic Cancer) 12/2020 - 12/2014
11	Esophageal Neoplasms (Esophageal Cancer) 04/2020 - 11/2013
10	Carcinoma (Carcinomatosis) 01/2019 - 12/2000
9	Colorectal Neoplasms (Colorectal Cancer) 09/2018 - 05/2004
6	Neutropenia 01/2022 - 08/2012
5	Disease Progression 01/2021 - 05/2004
5	Hemorrhage 03/2019 - 10/2005
5	Ascites 12/2018 - 09/2003
5	Pathologic Constriction (Stenosis) 10/2017 - 01/2002
4	Anorexia 01/2022 - 01/2016
4	Leukopenia 01/2022 - 08/2012
3	Microsatellite Instability 10/2021 - 01/2019
3	Anemia 03/2019 - 01/2018
3	Fatigue 01/2018 - 11/2009
2	Pneumonia (Pneumonitis) 06/2022 - 11/2009
2	Margins of Excision 06/2022 - 04/2016
2	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 07/2020 - 11/2017
2	Linitis Plastica 05/2020 - 01/2019
2	Internal Hernia 04/2020 - 10/2017
2	Wounds and Injuries (Trauma) 05/2019 - 01/2019
2	Pain (Aches) 01/2019 - 01/2012
2	Diarrhea 01/2019 - 01/2018
2	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 01/2019 - 02/2012
2	Colonic Neoplasms (Colon Cancer) 07/2018 - 01/2017
2	Stomatitis 01/2018 - 08/2012
2	Hernia (Hernias) 10/2017 - 01/2006
2	Nausea 02/2017 - 01/2016
2	Vitamin E Deficiency 02/2017 - 08/2014
2	Vomiting 02/2017 - 10/2016
2	Infections 01/2016 - 11/2003

Drug/Important Bio-Agent (IBA)

26	Cisplatin (Platino)FDA LinkGeneric 01/2022 - 11/2003
17	Paclitaxel (Taxol)FDA LinkGeneric 01/2022 - 03/2006
13	Messenger RNA (mRNA)IBA 07/2020 - 07/2002
12	Docetaxel (Taxotere)FDA Link 01/2022 - 01/2009
9	Biomarkers (Surrogate Marker)IBA 02/2022 - 01/2019
9	S-1 plus cisplatinIBA 03/2021 - 04/2010
8	NivolumabIBA 01/2022 - 12/2017
7	CreatinineIBA 01/2022 - 01/2013
7	Fluorouracil (Carac)FDA LinkGeneric 01/2020 - 11/2003
6	Oxaliplatin (Eloxatin)FDA LinkGeneric 02/2020 - 01/2017
5	Pharmaceutical PreparationsIBA 01/2022 - 12/2000
5	Trastuzumab (Herceptin)FDA Link 02/2020 - 12/2013
5	Irinotecan (Camptosar)FDA LinkGeneric 01/2019 - 03/2006
5	Capecitabine (Xeloda)FDA Link 01/2018 - 07/2012
4	Eicosapentaenoic AcidIBA 05/2022 - 05/2012
4	Proteins (Proteins, Gene)FDA Link 11/2021 - 01/2006
4	Gemcitabine FDA Link 07/2017 - 01/2015
4	Epidermal Growth Factor (EGF)IBA 01/2017 - 07/2012
4	Tissue Inhibitor of Metalloproteinase-1IBA 01/2009 - 05/2004
4	titanium silicide (TS-1)IBA 10/2005 - 12/2000
3	human ERBB2 proteinIBA 02/2020 - 11/2013
3	RamucirumabIBA 03/2019 - 12/2018
3	RNA (Ribonucleic Acid)IBA 01/2019 - 12/2004
3	TegafurIBA 09/2018 - 04/2010
2	Biological ProductsIBA 06/2022 - 10/2020
2	Indicators and Reagents (Reagents)IBA 03/2022 - 03/2015
2	Dihydrouracil Dehydrogenase (NADP) (Dihydropyrimidine Dehydrogenase)IBA 01/2022 - 08/2017
2	Prostaglandins AIBA 11/2021 - 01/2019
2	Eosine Yellowish-(YS) (Eosin)IBA 10/2021 - 11/2019
2	Monoclonal AntibodiesIBA 01/2021 - 12/2017
2	pembrolizumabIBA 01/2021 - 03/2019
2	Immune Checkpoint InhibitorsIBA 01/2021 - 01/2020
2	Imatinib Mesylate (Gleevec)FDA Link 07/2020 - 11/2017
2	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 07/2020 - 02/2017
2	Thymidylate SynthaseIBA 01/2020 - 01/2019
2	SteroidsIBA 03/2019 - 12/2017
2	Serum AlbuminIBA 03/2019 - 05/2012
2	C-Reactive ProteinIBA 03/2019 - 12/2017
2	Therapeutic UsesIBA 01/2019 - 01/2003
2	Immunoglobulin G (IgG)IBA 01/2019 - 12/2017
2	UracilIBA 09/2018 - 01/2018
2	Leucovorin (Folinic Acid)FDA Link 09/2018 - 11/2003
2	Antineoplastic Agents (Antineoplastics)IBA 05/2018 - 06/2009
2	polysaccharide-KIBA 01/2018 - 11/2011
2	AntibodiesIBA 12/2017 - 01/2014
2	Inhibins (Inhibin)IBA 07/2017 - 05/2014

Therapy/Procedure

120	Gastrectomy 10/2022 - 01/2002
71	Adjuvant Chemotherapy 11/2022 - 08/2010
64	Drug Therapy (Chemotherapy) 05/2022 - 01/2002
37	Therapeutics 01/2022 - 04/2002
33	Neoadjuvant Therapy 05/2022 - 12/2000
31	Lymph Node Excision (Lymph Node Dissection) 06/2022 - 01/2002
8	Esophagectomy 06/2022 - 03/2014
6	Immunotherapy 05/2022 - 11/2003
6	Splenectomy 10/2020 - 11/2016
4	Palliative Care (Palliative Therapy) 01/2021 - 10/2005
4	Combination Drug Therapy (Combination Chemotherapy) 01/2018 - 10/2005
3	Radiotherapy 05/2022 - 11/2016
3	Sutures (Suture) 11/2020 - 10/2017
3	Enhanced Recovery After Surgery 05/2019 - 12/2017
2	Length of Stay 05/2019 - 11/2010
2	Perioperative Care 01/2019 - 01/2019
2	Aftercare (After-Treatment) 11/2017 - 10/2015
2	Chemoradiotherapy 11/2016 - 11/2016